Organic & Biomolecular Chemistry

Impact factor: 3.423*
Publishing frequency: 48 issues per year
Indexed in MEDLINE
Chair: Anthony Davis

Scope

Organic & Biomolecular Chemistry (OBC) publishes original and high impact research and reviews in organic chemistry.

We welcome research that shows new or significantly improved protocols or methodologies in total synthesis, synthetic methodology or physical and theoretical organic chemistry as well as research that shows a significant advance in the organic chemistry or molecular design aspects of chemical biology, catalysis, supramolecular and macromolecular chemistry, theoretical chemistry, mechanism-oriented physical organic chemistry, medicinal chemistry or natural products.

Articles published in the journal should report new work which makes a highly-significant impact in the field. Routine and incremental work is generally not suitable for publication in the journal.

More details about key areas of our scope are below. In all cases authors should include in their article clear rationale for why their research has been carried out.

Organic synthesis: We welcome important research in all areas of organic synthesis, including studies on small organic molecules and biomolecules, and studies that report purely synthetic work without biological data. Total or multistep syntheses should report new or improved strategies or methods, or a more efficient route to the target compound. Methodology studies should show a significant improvement on known methods. Research that extends known methodology to a different class of compounds is generally not suitable, unless that class is significantly different in scope to previously reported methodology.

Physical and theoretical organic chemistry: We welcome studies that report new models of reactivity, selectivity, bonding or structure, or new computational methods and have relevance for the design of subsequent experiments. That relevance should be clearly justified in the paper. Relevance is perhaps most clearly demonstrated by the description of testable predictions derived from the results of the reported theoretical work; the tests of these predictions could be contained in the same paper in which the predictions are described. Computational research that merely reproduces experimental data is not suitable for OBC.

Chemical biology: We welcome articles that report new or improved methodologies in the chemical aspects of chemical biology, including design, development and use of chemical tools, chemical studies of biomolecules such as carbohydrates, proteins and nucleic acids or biological processes such as protein-protein interactions and epigenetics, and chemical methods such as imaging and labelling techniques.

Supramolecular, macromolecular and organic materials: We welcome studies that report important new work in the molecular design of supramolecular or macromolecular compounds or organic materials either with a strong component in organic synthesis or with novel organic structural features. You may wish to consider our materials journals for articles outside this scope.

Sensors: We publish articles describing sensors for ions and/or molecules provided that: (a) they address targets and situations of practical relevance; and (b) they represent significant and demonstrable improvements on previous methodology. In particular, sensors for species in artificial surroundings (for example, hydrophilic ions in organic solvents) will not typically be acceptable for publication.

Medicinal chemistry: We welcome studies that report significant synthetic or bioorganic research that is directed towards medicinal chemistry applications. Studies that show routine syntheses accompanied by biological testing are generally not suitable for OBC. Our sister journal, MedChemComm, is more suitable for articles that report significant research in core medicinal chemistry disciplines.

Natural products: We welcome articles that report new and interesting syntheses of natural products (see Organic Synthesis guidelines above) or chemical studies of biosynthetic pathways. Isolation or identification studies are welcome when the compound being reported:
1) Has a novel structural class with unreported carbon skeleton, unusual functional groups or unusual modifications and/or
2) Displays a potent or unexpected biological activity or an unexpected mechanism of action.
Routine isolation studies are not suitable for OBC.

Author benefits

Fast peer review and publication - average time to first decision (based on decisions made on all peer-reviewed articles in 2018):

15 days for Communications
22 days for Papers

Flexible submission format; submit in any reasonable format, and no template required
Optional accepted manuscript publication; have the unedited version of your article published shortly after acceptance
Easy submission and manuscript tracking online
Choice of submission routes; authors can choose either the Cambridge editorial office or submission to an associate editor
Unlimited free colour, both online and in print
High exposure; top papers highlighted in the wider scientific press
Broadest organic audience; synthetic, physical and biomolecular
Indexed in MEDLINE and other major databases

Chair

Anthony Davis, University of Bristol, UK

Associate editors

Christian Hackenberger, Leibniz-Institut für Molekulare Pharmakologie and Humboldt Universität zu Berlin, Germany

Motomu Kanai, University of Tokyo, Japan

Elizabeth Krenske, University of Queensland, Australia

Lei Liu, Tsinghua University, China

Santanu Mukherjee, Indian Institute of Science, Bangalore, India

Scott Silverman, University of Illinois at Urbana-Champaign, USA

Editorial board members

Ivan Huc, Ludwig-Maximilian University of Munich, Germany

Geraldine Masson, Institut de Chimie des Substances Naturelles (CNRS), France

G Mugesh, Indian Institute of Science, Bangalore, India

Corinna Schindler, University of Michigan, USA

Dean Tantillo, University of California, Davis, USA

Kyo Han Ahn, Pohang University of Science and Technology, Korea

Gonçalo Bernardes, University of Cambridge, UK

Barry Carpenter, Cardiff University, UK

David Chen, Seoul National University, Korea

Shunsuke Chiba, Nanyang Technological University, Singapore

Andre Cobb, Kings College London, UK

Steven Cobb, Durham University, UK

Ratmir Derda, University of Alberta, Canada

Antonio Echavarren, Autonomous University of Madrid, Spain

Margaret Faul, Amgen, USA

Ben Feringa, University of Groningen, Netherlands

Amar Flood, Indiana University Bloomington, USA

Carmen Galan, University of Bristol, UK

Sam Gellman, University of Wisconsin, USA

Krishna Kaliappan, Indian Institute of Technology Bombay, India

Mahesh Lakshman, The City College of New York, USA

Shih-Yuan Liu, Boston College, USA

Stephen Loeb, University of Windsor, Canada

David Lupton, Monash University, Australia

Ilan Marek, Israel Institute of Technology, Israel

Keiji Maruoka, Kyoto University, Japan

Dhevalapally Ramachary, University of Hyderabad, India

Sripada Ramasastry, Indian Institute of Science Education and Reasearch Mohali, India

Paolo Scrimin, University of Padova, Italy

Oliver Seitz, Humboldt University of Berlin, Germany

Jay Siegel, University of Zürich, Switzerland

Corey Stephenson, University of Michigan, USA

Keith Stubbs, University of Western Australia, Australia

Mark Taylor, University of Toronto, Canada

Georgios Vassilikogiannakis, University of Crete, Greece

Helma Wennemers, ETH Zürich, Switzerland

Peter Wipf, University of Pittsburgh, USA

Shuli You, Shanghai Institute of Organic Chemistry, China

Li He Zhang, Peking University, China

Jian Zhou, East China Normal University, China

Richard Kelly, Executive Editor, ORCID 0000-0003-2380-9315

James Anson, Deputy Editor, ORCID 0000-0002-7164-5696

Catherine Hodges, Development Editor

Helen Saxton, Editorial Production Manager, ORCID 0000-0002-1560-7396

Nicola Burton, Publishing Editor

Roxane Owen, Publishing Editor, ORCID 0000-0002-4553-233X

Alex Rowles, Publishing Editor

Donna Smith, Publishing Editor

Amy Cook, Editorial Assistant

Jane Chan, Publishing Assistant

Article types

Organic & Biomolecular Chemistry publishes:

Communications
Full papers
Reviews
Comments

See more information about these article types

Communications

Urgent accounts of highly-important new research. No strict page limit but generally up to five journal pages in length. Research findings should be presented in a succinct and informative way, emphasising the importance and potential impact of the research.

Authors are particularly encouraged to prepare a title and abstract which concisely summarise the key findings of their research and their importance, avoiding the use of non-standard abbreviations, acronyms and symbols, as this will enable potential readers to quickly understand the significance of the research. Authors should also consider using recognisable, searchable terms, as around 70% of our readers come directly via search engines. The table of contents graphic should give the reader a clear indication of the topic of the study, eg by showing key compounds.

Full papers

Full accounts of important original research. Full papers may be an expansion of work previously published in a Communication; however, the new work reported must represent a significant extension on what was previously published.

The importance and potential impact of the research should be emphasised. Authors are particularly encouraged to prepare a title and abstract which concisely summarise the key findings of their research and their importance, avoiding the use of non-standard abbreviations, acronyms and symbols, as this will enable potential readers to quickly understand the significance of the research. Authors should also consider using recognisable, searchable terms, as around 70% of our readers come directly via search engines. The table of contents graphic should give the reader a clear indication of the topic of the study, eg by showing key compounds.

Reviews

Concise and critical reviews of important or emerging topics in organic chemistry. Easy to read and covering current areas of interest, rather than comprehensive reviews of the literature. Download our author guidelines for Organic and Biomolecular Chemistry Reviews (PDF).

Comments

Comments and Replies are a medium for the discussion and exchange of scientific opinions between authors and readers concerning material published in Organic & Biomolecular Chemistry.

For publication, a Comment should present an alternative analysis of and/or new insight into the previously published material. Any Reply should further the discussion presented in the original article and the Comment. Comments and Replies that contain any form of personal attack are not suitable for publication.

Comments that are acceptable for publication will be forwarded to the authors of the work being discussed, and these authors will be given the opportunity to submit a Reply. The Comment and Reply will both be subject to rigorous peer review in consultation with the journal’s Editorial Board where appropriate. The Comment and Reply will be published together.

Journal specific guidelines

The following guidelines are journal specific. For general guidance on preparing an article please visit our Prepare your article page, the content of which is relevant to all of our journals.

See more about Journal specific guidelines

Data and supporting information

Characterisation of compounds

OBC has minimum characterisation data requirements for i) new compounds, and ii) known compounds that have been synthesised by a new method. These requirements are described below.

There is no requirement to provide characterisation data for the synthesis of a known compound by a literature method; in these cases authors should provide a literature reference to previously-published characterisation data for that compound. However, authors are welcome to provide details of improved experimental protocols, more detailed characterisation data, or selected data from known compounds.

Organic compounds

Data required for both new compounds and known compounds synthesised by a new method
Copies of ¹H NMR spectra (which contain no more than trace peaks that are not assigned to the structure in question) should be supplied as supplementary material. Spectra should be of high resolution and displayed in landscape, ideally with one spectrum per page.

Data required for new compounds only (in addition to the data specified above)
It is the responsibility of authors to provide fully convincing evidence for the homogeneity, purity and identity of all compounds they claim as new. This evidence is required to establish that the properties and constants reported are those of the compound with the new structure claimed. Referees will assess, as a whole, the evidence presented in support of the claims made by the authors.

The following are required in all cases:

Complete numerical listings of ¹H,¹³C NMR peaks in support of the assigned structure
Copies of ¹³C NMR spectra (containing no more than trace peaks that are not assigned to the structure in question) as supplementary material. Spectra should be of high resolution and displayed in landscape, ideally with one spectrum per page
High resolution mass spectroscopy (HRMS), with a found value within 0.003m/z unit of the calculated value of a parent-derived ion. Elemental analysis data may be provided if HRMS is not available.

The following are required in specific cases:

Infrared spectra should be supplied to support functional group transformations
Specific rotation should be supplied for non-racemic compounds
The determination of enantiomeric excess of nonracemic, chiral substances should be supported with either GC/HPLC traces with retention times for both enantiomers and separation conditions (that is, chiral support, solvent and flow rate) or copies of the spectra for Mosher Ester/Chiral Shift Reagent analysis
Copies of 2D NMR and related experiments (that is, NOE, etc) should be supplied as supplementary material in cases where these data are used to assign the structure
Proof of absolute configuration should be supplied for chiral compounds. In cases where this is not available, a statement as to why this cannot be supplied should be included in the manuscript. For closely related structures assignment by analogy is acceptable if the configuration of one compound in the series is unambiguously assigned

In a small number of cases some of the characterisation techniques which are normally required for new organic compounds may not be applicable or possible to obtain (for example, for some supramolecular systems). In these circumstances the evidence for identity and purity will be judged on a case-by-case basis by the editor and referees.

Biomolecules (such as enzymes, peptides, proteins, DNA/RNA, oligosaccharides, oligonucleotides)

It is not possible to give hard and fast requirements for the characterisation of biomolecules as the applicability and availability of different techniques often depends on molecule type or size. In all cases LC-MS or equivalent data (for example, HPLC data plus MS data on collected peaks) should be supplied for key synthetic intermediates, and as evidence of purity and identity of the final compound.

Additional data, such as high field ¹H,¹³C NMR, X-ray crystallography or sequencing data (for proteins and oligonucleotides) may be provided if available. In some cases authors may be required to provide some of this additional data if it is thought necessary by the referees.

For new derivatives comprising modified monomers, the usual organic chemistry analytical requirements for the novel monomer must be provided (see Organic compounds). It is not however necessary to provide this level of characterisation for the oligomer into which the novel monomer is incorporated.

Computational work

Papers which report QM work should include, as a minimum atomic coordinates as .mol2 or .pdb files, energies and number of imaginary frequencies for all computed stationary points. Intrinsic reaction coordinate (IRC) plots should be included if IRC calculations were run. Where computational work is included as part of a synthetic study, theoretical characterization (for example, computational NMR, VCD) of products and important synthetic intermediates is appropriate for inclusion on its own.

Guidelines on writing titles, abstracts & table of contents information

The title, abstract and graphical abstract are the first parts of your manuscript that editors, referees and potential readers will see, and once published they play a major part in a researcher’s decision to read your article. Therefore it’s important that these clearly and concisely show the main findings of your research and why they are important.

Title
The title should be short and straightforward to appeal to a general reader, but detailed enough to properly reflect the contents of the article.

Keep it relatively short – between 8 and 15 words is ideal
Use easily recognisable words and phrases that can be read quickly
Use general terms for compounds and procedures rather than specific nomenclature or very specialised terms
Avoid using non-standard abbreviations and symbols
Avoid using subjective terms such as “novel”
Use keywords and familiar, searchable terms – these can increase the chances of your article appearing in search results. Around 70% of our readers come directly via search engines

Abstract
The abstract is a single paragraph which summarises the findings of your research. It will help readers to decide whether your article is of interest to them.

The length can vary from 50 to 250 words (or 40 to 75 words for Communications), but it should always be concise and easy to read with recognisable words and phrases
It should set out the objectives of the work, the key findings and why this research is important (compared to other research in its field)
It should emphasise (but not overstate) the significance and potential impact of the research in your article
Avoid including detailed information on how the research was carried out; this should be described in the main part of the manuscript
Like your title, make sure you use familiar, searchable terms and keywords

Table of contents information
This consists of a small graphic and short text which will appear in the table of contents and feeds – for example, RSS feeds.

The graphic should:

be 8 cm wide x 4 cm high
be a clear representation of what your research is about; consider what would grab the attention of a reader as they scan though article listings – for example, for synthetic articles a target compound or key reaction scheme work well
include only one or two key elements (as the graphics are small); it’s much better to have a small amount of information that stands out rather than a lot of information which is too small to understand
avoid using graphs or spectra
include text that is large enough to read and in Arial, Times or Helvetica font
avoid reusing figures from the article

The text should:

should be 15–25 words
focus only on the key findings and their importance, not the processes used; think about what would grab the attention of the potential reader and would encourage them to read the full article
use easily recognisable words and phrases that can be read quickly
not repeat the information given in the title

Examples of suitable titles, abstracts and table of contents information

Titles

Iron-catalyzed arylation of α-aryl-α-diazoesters
From DOI: 10.1039/C5OB02418H

Copper-catalyzed electrophilic amination using N-methoxyamines
From DOI: 10.1039/C5OB02167G

Anti-Selective aminofluorination of alkenes with amidines mediated by hypervalent iodine(III) reagents
From DOI: 10.1039/C5OB01854D

Lewis acid-promoted [2 + 2] cycloadditions of alkenes with aryl ketenes
From DOI: 10.1039/C5OB01837D

A versatile synthesis of chiral β-aminophosphines
From DOI: 10.1039/C5OB02439K

Ruthenium photoredox-triggered phospholipid membrane formation
From DOI: 10.1039/C6OB00290K

An alternative, unsuitable way of writing the final example above would be:

Ru(bpy₃)²⁺ 11-watt CFL-triggered tool reduces Cu(II) and initiates CuAAC reaction leading to phospholipid synthesis and in situ membrane formation

This title is too detailed and includes terms and compound names which are too specific (e.g.Ru(bpy₃)²⁺, CuAAC)

Abstracts

A method for the preparation of chiral β-aminophosphines having substituted P-aryl groups is described. Ring-opening of cyclic sulfamidates with metal diarylphosphinites yields β-aminophosphine oxides, which are then reduced to the corresponding phosphines. Effects of the diarylphosphinite countercation on the regioselectivity of the ring-opening reaction (P- versus O-alkylation) are discussed. This method enables the introduction of electron-deficient, electron-rich and sterically hindered diarylphosphino groups, as demonstrated by the synthesis of a series of novel, P-aryl-substituted β-aminophosphines derived from tert-leucinol, valinol and phenylglycinol. Access to these derivatives will create new opportunities for steric and electronic tuning of β-aminophosphine-derived chiral ligands and organocatalysts.

From DOI: 10.1039/C5OB02439K

Copper-catalysed electrophilic amination of a triarylboroxin using an N-methoxyamine to give quick access to a variety of anilines was reported. The reaction was especially useful for syntheses of functionalised anilines when combined with our previously reported nucleophilic addition to N-methoxyamides.

From DOI: 10.1039/C5OB02167G

Advanced glycation end products (AGEs) are associated with various diseases, especially during aging and the development of diabetes and uremia. To better understand these biological processes, investigation of the in vivo kinetics of AGEs, i.e., analysis of trafficking and clearance properties, was carried out by molecular imaging. Following the preparation of Cy7.5-labeled AGE-albumin and intravenous injection in BALB/cA-nu/nu mice, noninvasive fluorescence kinetics analysis was performed. In vivo imaging and fluorescence microscopy analysis revealed that non-enzymatic AGEs were smoothly captured by scavenger cells in the liver, i.e., Kupffer and other sinusoidal cells, but were unable to be properly cleared from the body. Overall, these results highlight an important link between AGEs and various disorders

From DOI: 10.1039/C6OB00098C

A new route to a tetracyclic lactam was developed and the product, called VG1, was found to inhibit nonsense-mediated mRNA decay at μM concentrations.
From DOI: 10.1039/c5ob02482j

Benzoyl-Oxyma is a highly crystalline, readily prepared, safer alternative to benzoyloxybenzotriazole, useful in the selective benzoylation of carbohydrate polyols.
From DOI: 10.1039/C5OB02092A

A platinum complex/peptide chimera shows specific DNA binding and covalent platination with potential as a novel chemotherapeutic.
From DOI: 10.1039/C5OB01885D

Information about drawing structures or schemes

When drawing structures or schemes, authors should use the correct sizes and settings in order to maintain consistency. These graphics should ideally be created in ChemDraw and they should be supplied at the size you wish them to appear in print, using the same drawing settings for all structures.

Templates are available on our Author templates & services page to help you produce clear chemical structures from several drawing programs (for example, ChemDraw) and you may also use the article templates to see how figures will look in the final manuscript. Full guidance on presentation of structures and other graphics is available on our Author guidelines page.

When submitting an article which contains structures or schemes to OBC, authors should pay particular attention to the following key points:

Graphic widths should be up to 8.3 cm (one-column) or 17.1 cm (two-column)
Graphics should ideally be created to fit these widths to avoid articles containing large amounts of white space
Graphic height should be a maximum of 23.3 cm
Use solid or hatched wedges to depict stereochemistry
It is important not to change the scale of a graphic to modify its width - this results in unevenly-sized graphics
Recommended text size is Arial 7pt and bond lengths 0.43 cm

Submitting incorrectly-formatted files will result in a request from the handling editor to provide revised versions.

Manuscript submission information

On submission authors are asked to supply details of the two previously published articles most related to the submission-one from the author’s own group and one from the wider community. Authors are also asked to supply a very brief statement about the novelty and importance of the research. These pieces of information will assist editors and referees in the peer review process.

Readership information

Academic and industrial scientists working in organic chemistry, supramolecular chemistry, chemical biology and physical organic chemistry.

Subscription information

OBC is part of collections RSC Gold and Core Chemistry

Print + online 2019: ISSN 1477-0520, £5,361 / $9,619
Online only 2019: ISSN 1477-0539, £5,106 / $9,161

*2017 Journal Citation Reports (Clarivate Analytics 2018)

** average time from receipt to first decision in 2018